Opportunity
Brain hypoxia, characterized by restricted blood flow to the brain, counts for 23% of all neonatal deaths worldwide making the development of an accurate and precise patient monitoring system a top maternal-fetal health priority.
Technology
Noninvasix's novel solution utilizes optoacoustic monitoring of cerebral venous oxygenation to accurately measure the amount of oxygen a baby is receiving in real time.